Health Care & Life Sciences » Pharmaceuticals | China National Medicines Corp. Ltd.

China National Medicines Corp. Ltd. | Mutual Funds

Mutual Funds that own China National Medicines Corp. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
6,753,320
2.43%
6,753,320
2.19%
12/31/2017
3,898,350
1.4%
0
0.18%
12/31/2017
2,817,111
1.01%
0
0.16%
12/31/2017
GTJA Allianz De-sheng Small Cap Selective Fund
2,334,300
0.84%
384,300
6.42%
12/31/2017
HSBC Jintrust Large Cap Equity Fund
2,206,900
0.8%
2,206,900
0.93%
12/31/2017
2,127,560
0.77%
1,554,571
2.06%
12/31/2017
E Fund Value Growth
1,746,832
0.63%
1,746,832
0.78%
12/31/2017
1,647,187
0.59%
1,647,187
1.12%
12/31/2017
Nanfang CSI 500 ETF
1,300,449
0.47%
-83,400
0.24%
12/31/2017
Fortune SG Power Portfolio
1,099,896
0.4%
399,935
2.47%
12/31/2017

About China National Medicines Corp.

View Profile
Address
12-A Yongwai West Alley
Beijing Beijing 100077
China
Employees -
Website http://www.cncm.com.cn
Updated 07/08/2019
China National Medicines Co., Ltd. engages in the distribution of pharmaceuticals. It wholesales Chinese patent drugs, antibiotics, biochemical and biological products, stupefacient, first class and second class psychotropic substances and vaccines, as well as engages in the provision of warehousing and logistics services. The company was founded on December 21, 1999 and headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.